Search

everythinglearnresearchcommunity

for

Search:↓

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

FOL-005 peptide may help treat excessive hair growth safely.

Lysocellin helps stop cell damage from etoposide and may prevent hair loss.

Compounds from the Sansevieria trifasciata plant might be effective for treating hair loss.

Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

The treatment effectively promotes hair regrowth in androgenetic alopecia without causing skin irritation.

Clascoterone may be an effective topical treatment for hair loss.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

BMP2 helps hair follicle stem cells become specialized by increasing PTEN, which causes autophagy.

New pregnane derivatives were more effective than finasteride at inhibiting a key enzyme for male pattern baldness.

Drugmakers are optimistic about targeting the Wnt pathway for new treatments despite past challenges.

Targeting SOX proteins may improve cancer treatment by restoring immune function.

New compounds with carborane showed anti-androgen effects similar to flutamide.

Androgens prevent hair growth by changing Wnt signals in cells.

Scientists found new, better-working inhibitors for a hormone-related enzyme.

CDK4/6 inhibitors can protect hair cells from chemotherapy damage.

CS-891 may effectively treat hair loss by blocking enzymes in hair follicles.

HST and HST/F promote hair growth and may help treat alopecia.

Certain drugs can reduce bladder muscle contractions, potentially helping treat bladder diseases.

New compounds may soon be tested to treat excessive hair growth in women.

Certain hydroxycinnamate derivatives may effectively inhibit enzymes linked to hair loss with low toxicity.

Cepharanthine effectively reduces Herpes Simplex Virus Type 1 by blocking certain cell pathways and promoting cell death.

The conclusion is that a treatment called cp-asiAR can reduce hair loss and promote hair growth, making it a potential new therapy for androgenetic alopecia.

Topical estrogen treatments did not change hair growth in certain mouse strains, questioning previous findings on their role in hair growth control.

Minoxidil analogs can be improved for hair growth inhibition by modifying specific parts of their structure.

Estradiol stops hair growth in mice, but an antagonist can reverse this effect.